Search

Searching with a thematic focus on HIV and AIDS, HIV and AIDS treatment and care

Showing 341-350 of 1199 results

Pages

• Document

  Processes and issues for improving access to medicines: the evidence base for domestic production and greater access to medicines

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC study explores whether the domestic production of HIV/AIDS, TB and malaria drugs in sub-Saharan Africa is sufficiently profitable to operate indefinitely, while at the same time increasing access to medicines by providing them at prices lower than from international sources. The study uses a model to simulate the cost structure of an imaginary enterprise manufacturing quality drugs.
• Document

  Leveraging the private sector for public health objectives: a briefing paper for DFID on technology transfer in the pharmaceuticals sector

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC study maps a variety of Technology Transfer (TT) experiences and analyses the motivations behind the enabling agreements. TT is defined as the dissemination of knowledge and expertise from developed country organisations to developing country organisations.
• Document

  The effect of changing intellectual property on pharmaceutical industry prospects in India and China: considerations for access to medicines

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC report explores the implications of changing Intellectual Property (IP) on access to medicines (ATM) in India and China by asking two key questions: how will the implementation of product patents affect the pharmaceutical industries in these countries; and what will happen to the supply of low-priced medicines domestically and internationally.
• Document

  Processes and issues for improving access to medicines: willingness and ability to utilise TRIPS flexibilities in non-producing countries

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC paper examines ways in which a non-producing country (NPD) can utilise TRIPS flexibilities, primarily focusing on importation. It also examines how to promote local production through pharmaceutical capacity building and through both compulsory and voluntary licensing.
• Document

  HIV/AIDS as a security issue in Africa: lessons from Uganda

  International Crisis Group, 2004

  This report is the third in a series on HIV/AIDS as a security issue from the International Crisis Group (ICG), and draws on the policy experience of Uganda. The report asserts that HIV/AIDS prevention and conflict prevention should go hand in hand: evidence suggests that war can lead to increased risks of HIV/AIDS and HIV/AIDS can make conflicts worse.
• Document

  HIV/AIDS and work: global estimates, impact and response, 2004

  International Labour Organization, 2004

  This major report, prepared by the ILO Programme on HIV/AIDS and the World of Work, is intended as a reference tool. Part One provides global estimates of the impact of HIV/AIDS on the world of work and outlines the macroeconomic impact of HIV/AIDS. It looks at the effects of HIV/AIDS on the private sector: the public sector and the informal economy; as well as its impact on women and children.
• Document

  HIV/AIDS treatment and prevention in India: modeling the cost and consequences

  Health, Nutrition and Population Division, Human Development Department, World Bank, 2004

  The report from the World Bank analyses three alternative plans for using and financing antiretroviral therapy (ART) in India: a minimally interventionist plan to strengthen the private sector’s ability to manage ART; a moderately interventionist plan to provide free ART to HIV-positive pregnant women; and a more generous plan to finance ART for the poorest 40 percent of all Indians with HIV infec
• Document

  Estimating the cost of providing home-based care for HIV/AIDS in Rwanda

  Partners for Health Reformplus, 2004

  This paper from Partners for Health Reformplus estimated the cost of home-based care for HIV in Rwanda based on a comparison of facility- and community-based programmes offering care in early 2004.
• Document

  Breaking down barriers: lessons on providing HIV treatment to injection drug users

  International Harm Reduction Development program, OSI, 2004

  This report, prepared by the International Harm Reduction Development (IHRD) program, is a collection of cases demonstrating that well-designed, supportive programmes, which address the needs of injecting drug users can help all individuals adhere to anti-retroviral therapy (ART) and take advantage of appropriate harm reduction services.
• Document

  Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township

  Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, 2004

  Many HIV-positive adults in South Africa are dependent on the resource-constrained public sector healthcare system. There is therefore a clear need for research on the costs and effectiveness of different treatments for HIV.

Pages